# A Clinical Study of Piperaquine, Pyronaridine, and Artesunate Administered in Combination in Healthy Adults

> **NCT07470424** · PHASE1 · NOT_YET_RECRUITING · sponsor: **University of Oxford** · enrollment: 24 (estimated)

## Conditions studied

- Malaria

## Interventions

- **DRUG:** Piperaquine
- **DRUG:** Artesunate-pyronaridine (Pyramax)
- **DRUG:** Piperaquine and artesunate-pyronaridine (Pyramax)

## Key facts

- **NCT ID:** NCT07470424
- **Lead sponsor:** University of Oxford
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06-01
- **Primary completion:** 2027-06-01
- **Final completion:** 2027-08-01
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2026-04-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07470424

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07470424, "A Clinical Study of Piperaquine, Pyronaridine, and Artesunate Administered in Combination in Healthy Adults". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07470424. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*